SLC7A5 and sarcoma: In the present study, we demonstrated that LAT1 is overexpressed in multiple sarcoma subtypes and confirmed the antitumor efficacy of LAT1-targeted alpha therapy, which may be broadly applicable across diverse sarcoma subtypes.